EGFR-TKI-resistant Non-small Cell Lung Cancer With Leptomeningeal Metastasis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which EGFR-TKI-resistant Non-small Cell Lung Cancer With Leptomeningeal Metastasis trials may be worth asking about

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Not Yet RecruitingPhase 1

NCT07702305

Safety and Efficacy of Intrathecal Sacituzumab Tirumotecan for Leptomeningeal Metastasis in EGFR-TKI-Resistant Non-Small…

This study is a Phase I, single-arm, single-center, dose-escalation clinical trial designed to investigate the safety and efficacy of intrathecal injection of s…

Location not specified15 participantsStarted 2026-06-23Updated 2026-07-14

Treatment: Sacituzumab tirumotecan